Harmony Biosciences (HRMY)
(Delayed Data from NSDQ)
$37.76 USD
+0.48 (1.29%)
Updated Sep 12, 2024 04:00 PM ET
After-Market: $37.75 -0.01 (-0.03%) 7:58 PM ET
3-Hold of 5 3
A Value C Growth C Momentum B VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 10/29/24 |
---|---|
Current Quarter | 0.60 |
EPS Last Quarter | 0.20 |
Last EPS Surprise | 600.00% |
ABR | 1.89 |
Earnings ESP
|
0.00% |
---|---|
Current Year | 2.19 |
Next Year | 3.49 |
EPS (TTM) | 1.95 |
P/E (F1) | 17.02 |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 184.97M | 198.17M | 710.55M | 827.60M |
# of Estimates | 2 | 2 | 2 | 1 |
High Estimate | 186.03M | 203.80M | 715.10M | 827.60M |
Low Estimate | 183.90M | 192.53M | 705.99M | 827.60M |
Year ago Sales | 160.27M | 168.41M | 582.02M | 710.55M |
Year over Year Growth Est. | 15.41% | 17.67% | 22.08% | 16.47% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.60 | 0.56 | 2.19 | 3.49 |
# of Estimates | 2 | 2 | 3 | 1 |
Most Recent Consensus | NA | NA | 2.52 | NA |
High Estimate | 0.75 | 0.80 | 2.52 | 3.49 |
Low Estimate | 0.45 | 0.31 | 1.63 | 3.49 |
Year ago EPS | 0.63 | 0.45 | 2.13 | 2.19 |
Year over Year Growth Est. | -4.76% | 24.44% | 2.82% | 59.36% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 1 | 1 | 2 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 1 | 1 | 1 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | 0.60 | 0.56 | 2.19 | 3.49 |
7 Days Ago | 0.60 | 0.56 | 2.19 | 3.49 |
30 Days Ago | 0.60 | 0.56 | 2.19 | 3.49 |
60 Days Ago | 0.57 | 0.52 | 2.02 | 3.47 |
90 Days Ago | 0.57 | 0.52 | 1.96 | 3.47 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 0.60 | 0.56 | 2.19 | 3.49 |
Zacks Consensus Estimate | 0.60 | 0.56 | 2.19 | 3.49 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 0.20 | 0.67 | 0.45 | 0.63 | NA |
Estimate | -0.04 | 0.64 | 0.74 | 0.67 | NA |
Difference | 0.24 | 0.03 | -0.29 | -0.04 | -0.02 |
Surprise | 600.00% | 4.69% | -39.19% | -5.97% | 139.88% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more